Search Results

CAL-101 (Idelalisib, GS-1101) 50mg  | 99.57%

APEXBIO TECHNOLOGY LLC

PI3K inhibitor PI3K/Akt/mTOR Signaling|PI3K

More Information Supplier Page

×

CAL-101 (Idelalisib, GS-1101)

CAL-101 (Idelalisib, GS-1101) 20mg  | 99.57%

APEXBIO TECHNOLOGY LLC

PI3K inhibitor PI3K/Akt/mTOR Signaling|PI3K

More Information Supplier Page

×

CAL-101 (Idelalisib, GS-1101)

CAL-101 (Idelalisib, GS-1101) 5mg  | 99.57%

APEXBIO TECHNOLOGY LLC

PI3K inhibitor PI3K/Akt/mTOR Signaling|PI3K

More Information Supplier Page

×

CAL-101 (Idelalisib, GS-1101)

CAL-101 (Idelalisib, GS-1101) Evaluation Sample  | 99.57%

APEXBIO TECHNOLOGY LLC

PI3K inhibitor PI3K/Akt/mTOR Signaling|PI3K

More Information Supplier Page

×

CAL-101 (Idelalisib, GS-1101)

CAL-101 (Idelalisib, GS-1101) 10mM (in 1mL DMSO)  | 99.57%

APEXBIO TECHNOLOGY LLC

PI3K inhibitor PI3K/Akt/mTOR Signaling|PI3K

More Information Supplier Page

×

CAL-101 (Idelalisib, GS-1101)

Vemurafenib (PLX4032, RG7204) 10mg  | 98.36%

APEXBIO TECHNOLOGY LLC

BRAF kinase inhibitor MAPK Signaling|MEK1/2

More Information Supplier Page

×

Vemurafenib (PLX4032, RG7204)

Vemurafenib (PLX4032, RG7204) 50mg  | 98.36%

APEXBIO TECHNOLOGY LLC

BRAF kinase inhibitor MAPK Signaling|MEK1/2

More Information Supplier Page

×

Vemurafenib (PLX4032, RG7204)

Vemurafenib (PLX4032, RG7204) 200mg  | 98.36%

APEXBIO TECHNOLOGY LLC

BRAF kinase inhibitor MAPK Signaling|MEK1/2

More Information Supplier Page

×

Vemurafenib (PLX4032, RG7204)

Vemurafenib (PLX4032, RG7204) 500mg  | 98.36%

APEXBIO TECHNOLOGY LLC

BRAF kinase inhibitor MAPK Signaling|MEK1/2

More Information Supplier Page

×

Vemurafenib (PLX4032, RG7204)

Vemurafenib (PLX4032, RG7204) 1000mg  | 98.36%

APEXBIO TECHNOLOGY LLC

BRAF kinase inhibitor MAPK Signaling|MEK1/2

More Information Supplier Page

×

Vemurafenib (PLX4032, RG7204)